Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Lipigon Pharmaceuticals AB (publ)
  6. News
  7. Most relevant
    LPGO   SE0015382072

LIPIGON PHARMACEUTICALS AB (PUBL)

(LPGO)
  Report
Delayed Nasdaq Stockholm  -  05/20 10:20:33 am EDT
2.540 SEK   -5.58%
05/03Lipigon Pharmaceuticals AB Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/27Lipigon Receives CTA Approval for Lipid-Lowering Candidate Lipisense
CI
03/10Lipigon Pharmaceuticals AB Submits CTA for Lipid-Lowering Drug Candidate Lipisense
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about LIPIGON PHARMACEUTICALS AB (PUBL)
05/03Lipigon Pharmaceuticals AB Reports Earnings Results for the First Quarter Ended March 3..
CI
04/27Lipigon Receives CTA Approval for Lipid-Lowering Candidate Lipisense
CI
03/10Lipigon Pharmaceuticals AB Submits CTA for Lipid-Lowering Drug Candidate Lipisense
CI
03/01Lipigon Pharmaceuticals AB Confirms Patent Application for Drug Candidate Lipisense in ..
CI
02/24Lipigon Pharmaceuticals AB Reports Earnings Results for the Fourth Quarter and Full Yea..
CI
02/02Lipigon Pharmaceuticals AB Ready to Apply for Clinical Trials After Successful Completi..
CI
01/14Lipigon Pharmaceuticals AB Completes Another Preclinical Study with Drug Candidate Lipi..
CI
2021Lipigon Announces Positive Results from Preclinical Study for Lipid-Lowering Drug Candi..
CI
2021Lipigon Pharmaceuticals AB Reports Earnings Results for the Third Quarter and Nine Mont..
CI
2021Lipigon Pharmaceuticals AB and 5Prime Sciences Enter Partnership to Optimize Coming Cli..
CI
2021Lipigon Pharmaceuticals AB Publ Reports Earnings Results for the Second Quarter Ended J..
CI
2021Lipigon Pharmaceuticals AB cancelled the acquisition of antisense drug candidates and p..
CI
2021Lipigon Pharmaceuticals AB has completed an IPO in the amount of SEK 50.007395 million.
CI
2021Lipigon Pharmaceuticals AB has filed an IPO in the amount of SEK 50.007395 million.
CI
2020Lipigon Pharmaceuticals AB signed a research, development, and transfer agreement to ac..
CI
2016Lipigon Pharmaceuticals AB announced that it has received funding from Almi Invest AB
CI
Upcoming event on LIPIGON PHARMACEUTICALS AB (PUBL)
08/30/22Interim 2022 Earnings Release
Upcoming sector events
07/19/22JOHNSON & JOHNSON : Interim 2022 Earnings Release
07/21/22ROCHE HOLDING AG : Interim 2022 Earnings Release
07/29/22ABBVIE INC. : Interim 2022 Earnings Release (Projected)
08/02/22PFIZER INC. : Interim 2022 Earnings Release (Projected)
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Other Pharmaceuticals